Form 4 for MAS Masco
Accepted 2021-10-29 00:00:00 ET · period of report 2021-10-28 · accession 0001225208-21-013340 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-29 | 2021-10-28 | MAS | Lindow John P | VP, CAO, Ctrl | M - OptEx | $25.28 | +67.0K | 83.5K | +407% | +$1.69M |
| D | 2021-10-29 | 2021-10-28 | MAS | Lindow John P | VP, CAO, Ctrl | S - Sale+OE | $65.00 | -67.0K | 29.6K | -69% | -$4.36M |
| DM | 2021-10-29 | 2021-10-28 | MAS | Lindow John P | VP, CAO, Ctrl | M - OptEx | — | -67.0K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-28 | M | A | 21,125 | $25.51 | 50,713 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-28 | M | A | 19,259 | $22.92 | 69,972 | D | — | — | |
| 3 | Common | Common Stock | 2021-10-28 | S | D | 67,009 | $65.00 | 29,588 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.74 to $65.30, inclusive. The reporting person undertakes to provide to Masco Corporation, any security holder of Masco Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. |
| 4 | Common | Common Stock | 2021-10-28 | M | A | 13,105 | $19.66 | 96,597 | D | — | — | |
| 5 | Common | Common Stock | 2021-10-28 | M | A | 13,520 | $33.75 | 83,492 | D | — | — | |
| 6 | Derivative | Employee Stock Option | 2021-10-28 | M | D | 13,520 | — | 3,380 | D | $33.75 · — to 2027-02-10 | 13,520 Common Stock | (F3) Grant of option under the Masco Corporation 2014 Long Term Stock Incentive Plan in transactions exempt under Rule 16b-3. (F4) This option, representing a right to purchase a total of 16,900 shares, is exercisable in five equal annual installments of 3,380 shares commencing February 10, 2018. |
| 7 | Derivative | Employee Stock Option | 2021-10-28 | M | D | 19,259 | — | 0 | D | $22.92 · — to 2025-02-11 | 19,259 Common Stock | (F3) Grant of option under the Masco Corporation 2014 Long Term Stock Incentive Plan in transactions exempt under Rule 16b-3. (F5) In connection with the spin-off of TopBuild Corp. by Masco Corporation ("Masco") on June 30, 2015, outstanding stock options granted under the Masco 2014 Long Term Stock Incentive Plan by Masco to all plan participants, including to the reporting person, were adjusted on a value neutral basis to preserve the options' pre-spin intrinsic value. (F6) This option became exercisable in five equal annual installments commencing February 11, 2016. |
| 8 | Derivative | Employee Stock Option | 2021-10-28 | M | D | 13,105 | — | 0 | D | $19.66 · — to 2024-02-12 | 13,105 Common Stock | (F3) Grant of option under the Masco Corporation 2014 Long Term Stock Incentive Plan in transactions exempt under Rule 16b-3. (F5) In connection with the spin-off of TopBuild Corp. by Masco Corporation ("Masco") on June 30, 2015, outstanding stock options granted under the Masco 2014 Long Term Stock Incentive Plan by Masco to all plan participants, including to the reporting person, were adjusted on a value neutral basis to preserve the options' pre-spin intrinsic value. (F7) This option became exercisable in five equal annual installments commencing February 12, 2015. |
| 9 | Derivative | Employee Stock Option | 2021-10-28 | M | D | 21,125 | — | 0 | D | $25.51 · — to 2026-02-10 | 21,125 Common Stock | (F3) Grant of option under the Masco Corporation 2014 Long Term Stock Incentive Plan in transactions exempt under Rule 16b-3. (F2) This option became exercisable in five equal annual installments commencing February 10, 2017. |